Source: FinanzNachrichten

Acousia Therapeutics: Acousia Therapeutics GmbH: Hearing loss company Acousia Therapeutics to present key learnings and data from lead development programs at US and European meetings in August and September

TÜBINGEN, Germany, Aug. 23, 2023 /PRNewswire/ -- Acousia Therapeutics GmbH to share key learnings and data from its lead candidate development programs - clinical stage ACOU085 and late preclinica...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Tim Boelke's photo - CEO of Acousia

CEO

Tim Boelke

CEO Approval Rating

90/100

Read more